<p>Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis. In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above.<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA approved products: Mobic (meloxicam) oral tablets" href="#reference-L11398">10</a></sup> Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been studied in the treatment of neuropathic pain. <sup class="text-reference-group"><a class="reference-popover-link" data-content="Bekker A, Kloepping C, Collingwood S: Meloxicam in the management of post-operative pain: Narrative review. J Anaesthesiol Clin Pharmacol. 2018 Oct-Dec;34(4):450-457. doi: 10.4103/joacp.JOACP_133_18. (PubMed ID 30774225)" href="#reference-A190189">1</a></sup></p><p>Meloxicam, in combination with <a href="https://go.drugbank.com/drugs/DB00297">bupivacaine</a>, is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.<sup class="text-reference-group"><a class="reference-popover-link" data-content="FDA Approved Drug Products: ZYNRELEF (bupivacaine and meloxicam) extended-release solution for injection" href="#reference-L34100">13</a></sup></p>